Tabula Rasa HealthCare (TRHC) Stock Price, News & Analysis

Company Overview

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.

Key Stats

• Today's Range: $10.50 to $10.50
• 50-Day Range: $10.37 to $10.50
• 52-Week Range: $3.15 to $10.50
• Volume: N/A
• Average Volume: 225,500 shs
• Market Capitalization: $284.13 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TRHC Stock Analysis - Frequently Asked Questions

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.15. The firm's revenue for the quarter was up 22.8% on a year-over-year basis.

When did Tabula Rasa HealthCare IPO?

Tabula Rasa HealthCare (TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Disc Medicine (IRON), Arista Networks (ANET), Builders FirstSource (BLDR) and Jabil (JBL).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TRHC
• CUSIP: N/A
• CIK: 1651561
• Web: www.tabularasahealthcare.com
• Phone: (866) 648-2767
• Fax: N/A
• Employees: 1,027
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.85)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-147,510,000.00
• Net Margins: -28.23%
• Pretax Margin: -17.99%
• Return on Equity: N/A
• Return on Assets: -8.80%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.57
• Quick Ratio: 1.47

Sales & Book Value

• Annual Sales: $299.52 million
• Price / Sales: 0.95
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.10) per share
• Price / Book: -5.00

Miscellaneous

• Outstanding Shares: 27,060,000
• Free Float: 18,857,000
• Market Cap: $284.13 million
• Optionable: Optionable
• Beta: 1.57